ADMA Biologics (ADMA) said Monday it doesn't expect the latest US tariffs on foreign goods and services to have any impact on its supply chain or production operations.

The company's manufacturing operations, end-market sales, and customer engagements are all conducted exclusively within the US, Chief Executive Adam Grossman said.